umu.sePublications
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Overall survival benefit and impact on skeletal-related events for radium-223 chloride (Alpharadin) in the treatment of castration-resistant prostate cancer (CRPC) patients with bone metastases: A phase III randomized trial (ALSYMPCA)
Show others and affiliations
2012 (English)In: European urology. Supplement, ISSN 1569-9056, E-ISSN 1878-1500, Vol. 11, no 1, p. E130-U523Article in journal, Meeting abstract (Other academic) Published
Place, publisher, year, edition, pages
Amsterdam: Elsevier, 2012. Vol. 11, no 1, p. E130-U523
National Category
Urology and Nephrology
Identifiers
URN: urn:nbn:se:umu:diva-55537ISI: 000303001300181OAI: oai:DiVA.org:umu-55537DiVA, id: diva2:528438
Available from: 2012-05-25 Created: 2012-05-21 Last updated: 2017-12-07Bibliographically approved

Open Access in DiVA

No full text in DiVA

Search in DiVA

By author/editor
Widmark, Anders
By organisation
Oncology
In the same journal
European urology. Supplement
Urology and Nephrology

Search outside of DiVA

GoogleGoogle Scholar

urn-nbn

Altmetric score

urn-nbn
Total: 118 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf